EcoDrugPlus

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMMSG00000007812
Gene Symbol: TUBB4A
1 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSMMSG00000012157
Gene Symbol: TUBB4B
1 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSMMSG00000012937
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSMMSG00000005300
Gene Symbol: TUBB
1 Cross references
291 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMMSG00000019953
Gene Symbol: TP53
1 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMMSG00000009581
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSMMSG00000020791
Gene Symbol: TH
1 Cross references
118 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSMMSG00000002377
Gene Symbol: TYK2
1 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSMMSG00000010902
Gene Symbol: TIE1
1 Cross references
203 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSMMSG00000023072
Gene Symbol: UTS2R
1 Cross references
102 Possible Orthologues:

Utrophin

Ensembl ID : ENSMMSG00000002828
Gene Symbol: UTRN
1 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSMMSG00000007348
Gene Symbol: VEGFA
1 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).